{"abstract": "Closing the Cordis division in the face of dwindling market share, the company expects to trim 900 to 1,000 jobs this year.", "web_url": "https://www.nytimes.com/2011/06/16/health/16stent.html", "snippet": "Closing the Cordis division in the face of dwindling market share, the company expects to trim 900 to 1,000 jobs this year.", "lead_paragraph": "Johnson & Johnson announced on Wednesday that it would stop manufacturing drug-coated heart stents by the end of the year, abandoning an intensely competitive $4 billion market after a series of setbacks for the company and rising concerns about the use of stents in some patients.", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [], "headline": {"main": "Johnson & Johnson to End Line of Drug-Coated Heart Stents", "kicker": null, "content_kicker": null, "print_headline": "Johnson & Johnson to End Line of Drug-Coated Heart Stents", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Medical Devices", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 2, "major": "N"}, {"name": "subject", "value": "Stents (Medical Devices)", "rank": 3, "major": "N"}], "pub_date": "2011-06-15T19:48:32+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "byline": {"original": "By Duff Wilson", "person": [{"firstname": "Duff", "middlename": null, "lastname": "Wilson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/52033430-34e6-55e0-aaa3-19baa38d3896", "word_count": 588, "uri": "nyt://article/52033430-34e6-55e0-aaa3-19baa38d3896"}